Peripheral Blood Stem Cell Transplantation
"Peripheral Blood Stem Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation of PERIPHERAL BLOOD STEM CELLS. It is a less invasive alternative to direct marrow harvesting of hematopoietic stem cells. Enrichment of stem cells in peripheral blood can be achieved by inducing mobilization of stem cells from the BONE MARROW.
| Descriptor ID |
D036102
|
| MeSH Number(s) |
E02.095.147.500.500.500.500 E04.936.225.687.500.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Peripheral Blood Stem Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Peripheral Blood Stem Cell Transplantation".
This graph shows the total number of publications written about "Peripheral Blood Stem Cell Transplantation" by people in this website by year, and whether "Peripheral Blood Stem Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 6 | 4 | 10 |
| 2018 | 7 | 2 | 9 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Peripheral Blood Stem Cell Transplantation" by people in Profiles.
-
COVID-19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experience. Br J Haematol. 2021 08; 194(4):e74-e77.
-
Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma. Transfus Apher Sci. 2021 Oct; 60(5):103197.
-
How the COVID-19 pandemic changed cellular therapy at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital. Transfusion. 2020 09; 60(9):1905-1909.
-
Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia. Biol Blood Marrow Transplant. 2020 07; 26(7):e161-e166.
-
Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin. Haematologica. 2020 04; 105(4):1138-1146.
-
Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMT. Eur J Cancer. 2019 01; 106:212-219.
-
Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation. Int J Hematol. 2019 Feb; 109(2):197-205.
-
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia. Am J Hematol. 2018 10; 93(10):1211-1219.
-
Reply to Author. Biol Blood Marrow Transplant. 2018 10; 24(10):2166.
-
Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products. Leuk Lymphoma. 2018 12; 59(12):2829-2835.